Wilforlide A

CAS : 84104-71-2

Ref. 3D-FW65700

Informations sur le produit

• Nom: Wilforlide A
• Synonymes: (-)-Abruslactone A, 4,2-(Epoxymethano)picene, olean-12-en-29-oic acid deriv., Olean-12-En-29-One, 22,29-Epoxy-3-Hydroxy-, (3Beta,22Alpha)-, Olean-12-en-29-oic acid, 3,22-dihydroxy-, γ-lactone, (3β,20α,22α)-, Regelide

Description

Wilforlide A is a novel anticancer drug that inhibits the growth of cancer cells by inhibiting amino transferase and blocking the synthesis of DNA. Wilforlide A has synergistic effects when used in combination with tripterygium wilfordii, a Chinese herb, and moronic acid, an extract from Tripterygium wilfordii. Wilforlide A also has anti-inflammatory properties and can be used to treat autoimmune diseases. The efficacy of Wilforlide A was evaluated using surface methodology on human skin squamous carcinoma samples. It was found that Wilforlide A had no cytotoxicity when applied to these cells. In addition, it inhibited tumor growth in mice inoculated with human squamous carcinoma cells. These findings show that Wilforlide A is a potential candidate for treating squamous carcinoma patients.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 454.68 g/mol
• Formule: C₃₀H₄₆O₃
• Degré de pureté: Min. 95%
• Couleur/Forme: Powder